import serviceImage from '@/assets/ade_pde_oel_oeb_reports.png';
const link = '/services/ade-pde-oel/cross-contamination';

export default {
  slug: 'cross-contamination',
  parentSlug: 'ade-pde-oel',
  service_id: 'cross_contam_001',
  report_type: 'Comprehensive Cross-Contamination Risk Assessment',
  title: 'Pharmaceutical Cross-Contamination Control Services',
  name: 'Cross-Contamination Risk Management',
  description:
    'End-to-end contamination risk solutions combining HBEL analysis, Risk-MaPP implementation, and facility design optimization for compliant multi-product manufacturing.',
  full_description:
    'Our cross-contamination assessment service provides pharmaceutical manufacturers with a complete contamination control strategy from scientific basis to practical implementation. We conduct facility-wide risk evaluations using HBEL/PDE thresholds, implement ISPE Risk-MaPP methodology, and provide actionable engineering controls. Our approach covers product-to-product risks, cleaning validation support, and facility design optimization—all aligned with EMA, FDA, and WHO requirements for shared facilities.',
  estimated_duration: '7-12 business days (expedited options available)',
  deliverables: [
    'Comprehensive HBEL-based risk assessment report',
    'Risk-MaPP implementation roadmap',
    'Facility contamination risk heat map',
    'Equipment-specific risk profiles',
    'Cleaning validation gap analysis',
    'PDE-justified acceptance limits',
    'Design improvement recommendations (HVAC, material flow, segregation)',
    'Regulatory compliance checklist',
    'Training materials for staff implementation',
  ],
  regulatory_basis: [
    'EMA Guideline on Setting Health-Based Exposure Limits (EMA/CHMP/CVMP/SWP/169430/2012)',
    'EMA Guideline on Shared Facilities (EMA/CHMP/CVMP/SWP/246844/2018)',
    'ICH Q9 Quality Risk Management (R1)',
    'ISPE Risk-Based Manufacture of Pharmaceutical Products (Risk-MaPP 2.0)',
    'WHO TRS 996 Annex 3: Guidelines on GMP for HVAC systems',
    'FDA Guidance for Industry: CGMP for Combination Products',
    'PIC/S PI 046-1 Annex 15: Validation and Qualification',
  ],
  requires_data_from_client: true,
  target_industry: [
    'Pharmaceutical Manufacturing',
    'Biologics Production',
    'Contract Development & Manufacturing (CDMO)',
    'API & Formulation Facilities',
    'Medical Device/Drug Combination Products',
    'Veterinary Pharmaceutical Manufacturers',
  ],
  expertise_area: [
    'Contamination Control Strategy',
    'Quality Risk Management',
    'Facility Design & Engineering',
    'Cleaning Validation',
    'Regulatory Compliance',
    'Occupational Health Safety',
  ],
  is_active: true,
  pageLink: link,
  icon: '⚠️',
  image: {
    path: serviceImage,
    alt: 'Pharmaceutical cross-contamination risk assessment and control services',
    caption: 'Science-based contamination control strategies for multi-product facilities.',
  },
  pageContent: {
    hero: {
      heading: 'Robust Cross-Contamination Risk Management Solutions',
      tagline: 'Safeguarding Pharmaceutical Manufacturing with Science-Driven Strategies',
      detail:
        'At Indivirtus Healthcare Services, we deliver comprehensive cross-contamination risk management strategies to ensure product safety and regulatory compliance in shared manufacturing facilities.',
    },
    overview: {
      heading: 'Overview',
      overviewCards: [
        {
          heading: 'What We Do',
          detail:
            'We provide facility-wide risk assessments and actionable contamination control strategies, using HBEL/PDE thresholds and ISPE Risk-MaPP methodology to ensure safe manufacturing processes.',
        },
        {
          heading: 'Why It Matters',
          detail:
            'Effective cross-contamination management prevents product adulteration, ensures patient safety, and meets stringent regulatory requirements for shared facilities.',
        },
        {
          heading: 'Our Role',
          detail:
            'As a trusted CRO, we deliver scientifically robust solutions, from risk evaluations to engineering controls, to optimize your facility and ensure compliance.',
        },
      ],
    },
    approach: {
      heading: 'Our Expert Approach',
      detail: [
        'Indivirtus leverages the ISPE Risk-MaPP methodology and HBEL/PDE thresholds to deliver tailored cross-contamination risk management solutions. Our certified toxicologists and regulatory experts conduct thorough facility-wide evaluations, identifying risks and recommending practical engineering controls. From cleaning validation support to facility design optimization, our strategies ensure compliance with global standards and operational excellence.',
      ],
    },
    deliverables: {
      heading: 'Service Deliverables',
      itemList: [
        'Comprehensive HBEL-based risk assessment report',
        'Risk-MaPP implementation roadmap',
        'Facility contamination risk heat map',
        'Equipment-specific risk profiles',
        'Cleaning validation gap analysis',
        'PDE-justified acceptance limits',
        'Design improvement recommendations (HVAC, material flow, segregation)',
        'Regulatory compliance checklist',
        'Training materials for staff implementation',
      ],
    },
    compliance: {
      heading: 'Regulatory Compliance & Guidelines',
      detail: [
        'Our cross-contamination risk management services adhere to stringent global standards, ensuring your shared facilities are compliant and audit-ready. By following leading regulatory guidelines, we provide robust, scientifically defensible solutions that support seamless market access.',
      ],
      regitemListulations: [
        'EMA Guideline on Setting Health-Based Exposure Limits (EMA/CHMP/CVMP/SWP/169430/2012)',
        'EMA Guideline on Shared Facilities (EMA/CHMP/CVMP/SWP/246844/2018)',
        'ICH Q9 Quality Risk Management (R1)',
        'ISPE Risk-Based Manufacture of Pharmaceutical Products (Risk-MaPP 2.0)',
        'WHO TRS 996 Annex 3: Guidelines on GMP for HVAC systems',
        'FDA Guidance for Industry: CGMP for Combination Products',
        'PIC/S PI 046-1 Annex 15: Validation and Qualification',
      ],
    },
    applications: {
      heading: 'Applications & Use Cases',
      detail: [
        'Our cross-contamination risk management services are critical for manufacturers operating shared facilities, introducing new products, or optimizing existing processes. These solutions are applied during facility design, product changeovers, and routine operations to prevent contamination and ensure product safety.',
        "Whether you're managing a multi-product facility or ensuring compliance for a new production line, our tailored strategies deliver operational confidence and regulatory success.",
      ],
    },
    conclusion: {
      heading: 'Why Choose Indivirtus',
      detail: [
        'Indivirtus Healthcare Services is a trusted partner for pharmaceutical manufacturers, delivering science-driven cross-contamination risk management solutions. Our team of certified toxicologists and regulatory experts ensures compliance with global standards, rapid turnaround times, and strict confidentiality. With a focus on industry best practices, we empower your facility to operate safely and efficiently.',
        'Choose Indivirtus for robust, actionable strategies that safeguard your products and reputation.',
      ],
    },
    cta: {
      heading: 'Ready to Mitigate Cross-Contamination Risks?',
      tagline: 'Partner with Indivirtus for expert solutions that ensure safety and compliance.',
      aria: 'Contact Indivirtus for Cross-Contamination Risk Management Services',
    },
  },
  gtm: {
    eventCategory: 'Quality Risk Services',
    eventAction: 'Service Inquiry',
    eventLabel: 'Cross-Contamination Assessment',
    customDimensions: {
      serviceTier: 'Comprehensive',
      regulatoryLevel: 'EMA/FDA/WHO',
    },
    dataLayerPush: {
      reportType: ['Risk Assessment', 'Facility Evaluation'],
      methodology: ['Risk-MaPP', 'HBEL'],
      complianceFramework: ['GMP Annex 1', 'ICH Q9'],
    },
  },
  schema: {
    '@context': 'https://schema.org',
    '@type': 'ProfessionalService',
    name: 'Pharmaceutical Cross-Contamination Risk Management',
    description: 'Complete contamination control solutions from scientific assessment to facility implementation.',
    serviceType: ['Risk Assessment', 'Facility Design', 'Regulatory Compliance'],
    provider: {
      '@type': 'Organization',
      name: 'Indivirtus',
      url: 'https://www.indivirtus.com',
      logo: 'https://www.indivirtus.com/logo.png',
      sameAs: [
        'https://www.linkedin.com/company/indivirtus-group-of-companies',
        'https://twitter.com/indivirtus',
        'https://www.facebook.com/Indivirtus',
        'https://www.instagram.com/indivirtus_healthcare',
      ],
    },
    areaServed: {
      '@type': 'Country',
      name: 'Global',
    },
    availableChannel: {
      '@type': 'ServiceChannel',
      serviceUrl: link,
      servicePhone: '+91-9131925456',
      servicePostalAddress: {
        '@type': 'PostalAddress',
        streetAddress: '522, Taj Plaza, TDI city, Sector 118',
        addressLocality: 'Mohali',
        addressRegion: 'Punjab',
        postalCode: '160059',
        addressCountry: 'India',
      },
      availableLanguage: ['English', 'German', 'Japanese', 'Mandarin'],
    },
    hasOfferCatalog: {
      '@type': 'OfferCatalog',
      name: 'Contamination Control Services',
      itemListElement: [
        {
          '@type': 'Offer',
          itemOffered: {
            '@type': 'Service',
            name: 'Facility-Wide Risk Assessment',
            description: 'Comprehensive evaluation of contamination risks across all products and processes.',
            serviceOutput: 'Risk Assessment Dossier',
          },
        },
        {
          '@type': 'Offer',
          itemOffered: {
            '@type': 'Service',
            name: 'Risk-MaPP Implementation',
            description: 'Full methodology application with documented risk controls and monitoring plans.',
            serviceOutput: 'Risk-MaPP Compliance Package',
          },
        },
        {
          '@type': 'Offer',
          itemOffered: {
            '@type': 'Service',
            name: 'HBEL/PDE-Based Limits',
            description: 'Scientifically justified exposure limits for all products in shared spaces.',
            serviceOutput: 'HBEL Justification Report',
          },
        },
        {
          '@type': 'Offer',
          itemOffered: {
            '@type': 'Service',
            name: 'Facility Design Optimization',
            description: 'Engineering solutions for contamination control (HVAC, workflow, segregation).',
            serviceOutput: 'Design Improvement Plan',
          },
        },
      ],
    },
    offers: {
      '@type': 'Offer',
      priceCurrency: ['INR', 'USD', 'EUR'],
      price: 'From ₹75,000 per facility assessment',
      url: link,
      availability: 'https://schema.org/InStock',
      businessFunction: 'https://schema.org/ProvideService',
      eligibleCustomerType: 'https://schema.org/Business',
    },
  },
  faqSchema: {
    '@context': 'https://schema.org',
    '@type': 'FAQPage',
    mainEntity: [
      {
        '@type': 'Question',
        name: 'What methodology do you use for contamination risk assessments?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'We combine ISPE Risk-MaPP methodology with HBEL/PDE-based limits and facility-specific FMEA (Failure Mode Effects Analysis). Our approach includes: 1) Product grouping by hazard characteristics, 2) Process flow mapping, 3) Facility design evaluation, 4) Cleaning process assessment, and 5) Cross-contamination risk scoring matrix. This comprehensive method ensures all potential contamination pathways are identified and controlled.',
        },
      },
      {
        '@type': 'Question',
        name: 'How do you determine appropriate cleaning validation limits?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'We establish limits through a 4-step process: 1) Calculate HBEL/PDE values for all products, 2) Determine worst-case product scenarios, 3) Apply health-based exposure limits to equipment surfaces, and 4) Incorporate analytical detection capability. Our reports include ready-to-use limit justifications with safety margins that meet EMA/FDA expectations for shared facility operations.',
        },
      },
      {
        '@type': 'Question',
        name: 'What facility design elements most impact contamination risk?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'Key design factors include: 1) HVAC system zoning and pressure cascades, 2) Material and personnel flow patterns, 3) Equipment placement and segregation, 4) Surface finishes and cleanability, 5) Airlock design and operation, and 6) Utility system layouts. We evaluate all these elements and provide prioritized recommendations for both new facilities and retrofits.',
        },
      },
      {
        '@type': 'Question',
        name: 'How often should cross-contamination risks be reassessed?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'We recommend annual reviews with trigger-based reassessments for: 1) New products introduced, 2) Process changes, 3) Facility modifications, 4) Regulatory updates, or 5) Adverse findings in environmental monitoring. Our service includes optional annual review packages to maintain continuous compliance.',
        },
      },
      {
        '@type': 'Question',
        name: 'Can you help prepare for regulatory inspections on contamination control?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'Yes, we offer: 1) Mock inspection preparation, 2) Documentation gap analysis, 3) Staff training on contamination control justification, and 4) On-call expert support during actual inspections. Our team includes former regulators who understand exactly what inspectors look for in shared facility evaluations.',
        },
      },
      {
        '@type': 'Question',
        name: 'What deliverables will we receive for cleaning validation support?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'Our cleaning validation package includes: 1) Product-specific HBEL/PDE limits, 2) Worst-case product selection rationale, 3) Equipment grouping strategy, 4) Sampling location justification, 5) Acceptance limit calculations, and 6) Ready-to-use templates for protocols and reports. We also provide review of your existing validation documents if available.',
        },
      },
      {
        '@type': 'Question',
        name: 'What is cross-contamination risk management in pharmaceuticals?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'Cross-contamination risk management involves identifying, assessing, and mitigating risks of product-to-product or environmental contamination in pharmaceutical manufacturing. It ensures product safety and compliance by implementing robust control strategies.',
        },
      },
      {
        '@type': 'Question',
        name: 'How does Indivirtus ensure compliance with cross-contamination regulations?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'We align our services with EMA, FDA, WHO, and PIC/S guidelines, using HBEL/PDE thresholds and ISPE Risk-MaPP methodology. Our comprehensive assessments and actionable recommendations ensure audit-ready compliance for shared facilities.',
        },
      },
      {
        '@type': 'Question',
        name: 'What deliverables are included in the cross-contamination risk management service?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'Our deliverables include an HBEL-based risk assessment report, Risk-MaPP implementation roadmap, facility contamination risk heat map, equipment-specific risk profiles, cleaning validation gap analysis, PDE-justified acceptance limits, design improvement recommendations, regulatory compliance checklist, and staff training materials.',
        },
      },
      {
        '@type': 'Question',
        name: 'How long does a cross-contamination risk assessment take?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'The timeline varies based on facility complexity, but we typically deliver comprehensive assessments within 10-20 business days. Expedited services are available for urgent requirements.',
        },
      },
      {
        '@type': 'Question',
        name: 'Why is the ISPE Risk-MaPP methodology important?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'The ISPE Risk-MaPP methodology provides a systematic, risk-based approach to managing cross-contamination in shared facilities. It ensures scientifically defensible controls, aligning with global regulatory expectations and enhancing patient safety.',
        },
      },
    ],
  },
  meta: {
    title: 'Pharmaceutical Cross-Contamination Risk Assessment | HBEL & Risk-MaPP Experts - Indivirtus',
    description:
      'Comprehensive contamination control solutions combining HBEL analysis, Risk-MaPP implementation, and facility design optimization for compliant multi-product manufacturing.',
    keywords: [
      'pharma cross-contamination assessment',
      'Risk-MaPP implementation service',
      'HBEL contamination control',
      'PDE cleaning validation limits',
      'shared facility compliance',
      'multi-product manufacturing risk',
      'facility design optimization',
      'EMA contamination guidelines',
      'ISPE Risk-MaPP consultants',
      'cleaning validation support',
    ],
    ogTags: {
      type: 'service',
      image: serviceImage.src,
      url: `https://www.indivirtus.com${link}`,
      site_name: 'Indivirtus Quality Services',
      published_time: '2023-03-10T00:00:00+05:30',
      modified_time: '2023-07-15T00:00:00+05:30',
    },
    twitterCard: {
      card: 'summary_large_image',
      title: 'Pharma Cross-Contamination Control | Indivirtus',
      description: 'Complete contamination risk solutions from HBEL analysis to facility implementation.',
      image: serviceImage.src,
      site: '@indivirtus',
      creator: '@indivirtus_quality',
    },
    canonicalUrl: `https://www.indivirtus.com${link}`,
    robotsMeta: {
      index: true,
      follow: true,
      nocache: false,
      googlebot: 'index, follow',
    },
    additionalMeta: {
      viewport: 'width=device-width, initial-scale=1.0',
      themeColor: '#0066cc',
      author: 'Indivirtus Quality Team',
    },
  },
  assessmentTypes: [
    'Comprehensive Facility Risk Assessment',
    'Product-Specific HBEL Determination',
    'Cleaning Validation Limit Setting',
    'Risk-MaPP Implementation Package',
    'Facility Design Gap Analysis',
    'Regulatory Inspection Preparedness',
  ],
  serviceTiers: [
    {
      name: 'Basic Risk Evaluation',
      features: [
        'Single product assessment',
        'HBEL/PDE calculation',
        'Basic risk identification',
        'Regulatory compliance check',
      ],
      deliveryTime: '7-10 business days',
    },
    {
      name: 'Full Facility Assessment',
      features: [
        'Multi-product evaluation',
        'Risk-MaPP implementation',
        'Facility design review',
        'Cleaning validation support',
        'Risk heat mapping',
      ],
      deliveryTime: '10-15 business days',
    },
    {
      name: 'Enterprise Solution',
      features: [
        'Global facility network assessment',
        'Custom risk management system',
        'Regulatory inspection support',
        'Annual review program',
        'Dedicated quality engineer',
      ],
      deliveryTime: 'Custom timeline',
    },
  ],
};
